IMPACT OF THE HLA-DQA1*05 ALLELE ON LOSS OF RESPONSE AND PRESENCE OF ANTI-DRUG ANTIBODIES TO USTEKINUMAB IN CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS
Tariq Ahmad 1
María Dolores Martín-Arranz 2
Brigitta Brinkman 3
Christopher Gasink 4
Meijian Guan 5
Amy Hart 6
1 Nuffield Health Exeter Hospital, Exeter, United Kingdom
2 Hospital La Paz, Madrid, Spain
3 Janssen Pharmaceutica, Beerse, Belgium
4 Janssen Scientific Affairs, LLC, Horsham, United States
5 Janssen Research & Development, LLC, Spring House
6 Janssen Research & Development, LLC., Spring House
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]